NO925038D0 - Anordning for nedsettelse av medikamentets hudirriterendevirkninger - Google Patents

Anordning for nedsettelse av medikamentets hudirriterendevirkninger

Info

Publication number
NO925038D0
NO925038D0 NO925038A NO925038A NO925038D0 NO 925038 D0 NO925038 D0 NO 925038D0 NO 925038 A NO925038 A NO 925038A NO 925038 A NO925038 A NO 925038A NO 925038 D0 NO925038 D0 NO 925038D0
Authority
NO
Norway
Prior art keywords
drug
irritation
skin
mucosa
human
Prior art date
Application number
NO925038A
Other languages
English (en)
Other versions
NO925038L (no
Inventor
Michel J-N Cormier
Philip W Ledger
Alfred Amkraut
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO925038D0 publication Critical patent/NO925038D0/no
Publication of NO925038L publication Critical patent/NO925038L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Packaging For Recording Disks (AREA)
  • Passenger Equipment (AREA)
  • Steroid Compounds (AREA)
NO92925038A 1990-07-06 1992-12-30 Anordning for nedsettelse av medikamentets hudirriterendevirkninger NO925038L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/549,584 US5130139A (en) 1990-07-06 1990-07-06 Reduction or prevention of skin irritation by drugs
PCT/US1991/004685 WO1992000746A1 (en) 1990-07-06 1991-07-01 Reduction or prevention of skin irritation by drugs

Publications (2)

Publication Number Publication Date
NO925038D0 true NO925038D0 (no) 1992-12-30
NO925038L NO925038L (no) 1993-01-06

Family

ID=24193593

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92925038A NO925038L (no) 1990-07-06 1992-12-30 Anordning for nedsettelse av medikamentets hudirriterendevirkninger

Country Status (18)

Country Link
US (1) US5130139A (no)
EP (1) EP0538302B1 (no)
JP (1) JP3224814B2 (no)
AT (1) ATE121627T1 (no)
AU (1) AU641787B2 (no)
CA (1) CA2046014C (no)
DE (1) DE69109292T2 (no)
DK (1) DK0538302T3 (no)
ES (1) ES2071322T3 (no)
FI (1) FI930038A (no)
GR (1) GR3015934T3 (no)
IE (1) IE74152B1 (no)
MX (1) MX9100042A (no)
NO (1) NO925038L (no)
NZ (1) NZ238804A (no)
PT (1) PT98177B (no)
WO (1) WO1992000746A1 (no)
ZA (1) ZA915067B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100074C (en) * 1991-11-08 2003-08-12 Yasushi Sekiyama Biocidal self-adhesive and process for producing the same, as well as self-adhesive article and application thereof
US5843979A (en) * 1993-02-25 1998-12-01 Bristol-Myers Squibb Company Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
IL109036A (en) * 1993-03-19 1998-12-27 Cellegy Pharamaceuticals Inc Preparations for detachment of the epithelial barrier function and use of means for the preparation of such preparations
US6190894B1 (en) 1993-03-19 2001-02-20 The Regents Of The University Of California Method and compositions for disrupting the epithelial barrier function
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
EP0752898B1 (en) * 1994-03-30 1998-04-29 Alza Corporation Reduction of skin irritation during electrotransport delivery
WO1995034262A1 (en) * 1994-06-16 1995-12-21 Department Of The Army, Us Government Transdermal treatment of malaria
US5686100A (en) * 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
WO1997047355A1 (en) * 1996-06-12 1997-12-18 Alza Corporation Reduction of skin sensitization in electrotransport drug delivery
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US5981168A (en) 1998-05-15 1999-11-09 The University Of British Columbia Method and composition for modulating amyloidosis
US6699497B1 (en) * 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2006031856A2 (en) 2004-09-13 2006-03-23 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
WO2008092003A2 (en) 2007-01-25 2008-07-31 Honda Motor Co., Ltd. Vehicle systems control for improving stability
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
RU2675360C2 (ru) * 2013-02-08 2018-12-19 Луода Фарма Лимитед Способы лечения местных микробных инфекций
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US4274420A (en) * 1975-11-25 1981-06-23 Lectec Corporation Monitoring and stimulation electrode
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
US4250878A (en) * 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
CA1153427A (en) * 1978-12-11 1983-09-06 Patrick T. Cahalan Tape electrode
WO1981000964A1 (en) * 1979-10-10 1981-04-16 Cyclotech Med Ind Pain blocking bandage
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4419092A (en) * 1981-11-06 1983-12-06 Motion Control, Inc. Iontophoretic electrode structure
GB2124485B (en) * 1982-08-04 1986-06-04 Michael A Levy Penetrating topical medicament
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4702732A (en) * 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
FR2605221B1 (fr) * 1986-10-20 1989-09-01 Sanofi Sa Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
WO1990015599A1 (en) * 1989-06-19 1990-12-27 The Wellcome Foundation Limited Medicaments useful in cancer therapy and having antihistaminic properties

Also Published As

Publication number Publication date
WO1992000746A1 (en) 1992-01-23
DE69109292T2 (de) 1995-08-31
PT98177A (pt) 1993-08-31
IE912294A1 (en) 1992-01-15
DE69109292D1 (de) 1995-06-01
AU641787B2 (en) 1993-09-30
JPH05508643A (ja) 1993-12-02
US5130139A (en) 1992-07-14
ZA915067B (en) 1992-04-29
EP0538302B1 (en) 1995-04-26
ATE121627T1 (de) 1995-05-15
AU8104691A (en) 1992-02-04
JP3224814B2 (ja) 2001-11-05
CA2046014A1 (en) 1992-01-07
EP0538302A1 (en) 1993-04-28
PT98177B (pt) 1998-12-31
CA2046014C (en) 2003-05-20
GR3015934T3 (en) 1995-07-31
FI930038A0 (fi) 1993-01-05
FI930038A (fi) 1993-01-05
NO925038L (no) 1993-01-06
IE74152B1 (en) 1997-07-02
MX9100042A (es) 1992-02-28
ES2071322T3 (es) 1995-06-16
DK0538302T3 (da) 1995-09-18
NZ238804A (en) 1992-08-26

Similar Documents

Publication Publication Date Title
NO925038D0 (no) Anordning for nedsettelse av medikamentets hudirriterendevirkninger
WO1992002234A3 (en) Reduction or prevention of sensitization to drugs
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
NZ508526A (en) Opioid formulations for treating pain
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
WO2004056305A3 (en) Administration of capsaicinoids
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
GR3032523T3 (en) Therapeutic preparation for the transdermal administration of active substances
YU215090A (sr) Formulacija u obliku pilule za kontrolisano oslobađanje
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
SE9601528D0 (sv) Transdermally administered dextromethorphan as antitissue agent
EP0799618A3 (en) Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
Rudy Imiquimod (Aldara): modifying the immune response
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
Santoro et al. Assessment of skin safety of a new glyceryl trinitrate transdermal patch
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound